Got lots of interest in my RNA vaccine explainer yesterday. The most common follow up questions generally fell into two categories, well stated in the tweet below. I will answer both. 1/5
https://t.co/tchDCXS9yt
Kudos to our awesome ASP and NICU partnership for this QI publication highlighting a 66% decrease in IV vancomycin use led by @RanaHamdyMD. A little positivity among the chaos! #thinkbeforevanc https://t.co/xIPDH6aTl1